|
Pfizer, Bristol-Myers Pill Seen Leading $9 Billion Stroke Market
Pfizer Inc.’s and Bristol-Myers Squibb Co.’s Eliquis will lead the market for stroke-preventing blood thinners after 'best-in-class' clinical trial results that marry safety with effectiveness, analysts said. The twice-daily pill had a 31 percent lower risk of major bleeding, a feared side effect of blood thinners, than the current standard treatment, warfarin, researchers said.
read more...
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbott to invest $230mil to build nutrition manufacturing facility in China
Abbott announced that it will invest $230 million to build a state-of-the-art nutrition manufacturing facility in Jiaxing, China. The facility represents Abbott's largest investment in China to date and will manufacture premium powdered milk products for Chinese infants and children.
read more...
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stroke Prevention in Patients with Atrial Fibrillation
Data published today in the New England Journal of Medicine demonstrate that Bayer's once-daily, oral, direct Factor Xa inhibitor rivaroxaban successfully met the primary efficacy outcome while maintaining comparable overall bleeding rates versus warfarin in the ROCKET AF study.
read more...
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
L'Oreal USA Announces Recipients of 2011 For Women In Science Fellowships
L'Oreal USA Fellowships For Women In Science, a national awards program, was created to support the advancement of women in science and to encourage women to continue careers in scientific fields.
read more...
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Food makers face the big squeeze
Regulators, nutritionists say Americans need healthier choices amid an epidemic of obesity. They expect food producers to provide them, particularly by lowering sodium and sugar, ancient staples regarded now as potential public health scourges.
read more...
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
US Study: 'Amazing' killer T-cells wipe out leukemia
Three US cancer patients were brought back from the brink by a new therapy that turned their own immune cells into tumor killers, wiping out an advanced form of leukemia, researchers said.
read more...
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
[ Archive ]
|
